Who should be prioritised for COVID-19 vaccines?

doi:10.1016/S0140-6736(20)32224-8

. 2020 Nov 28;396(10264):1732-1733.

doi: 10.1016/S0140-6736(20)32224-8. Epub 2020 Oct 27.

Who should be prioritised for COVID-19 vaccines?

Zaki Hassan-Smith¹, Wasim Hanif², Kamlesh Khunti³

Affiliations

¹ University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK. Electronic address: z.hassansmith@bham.ac.uk.
² University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK.
³ Diabetes Research Centre, College of Medicine, Biological Sciences and Psychology, University of Leicester, Leicester, UK.

PMID: 33125934
PMCID: PMC7832613
DOI: 10.1016/S0140-6736(20)32224-8

Who should be prioritised for COVID-19 vaccines?

Zaki Hassan-Smith et al. Lancet. 2020.

. 2020 Nov 28;396(10264):1732-1733.

doi: 10.1016/S0140-6736(20)32224-8. Epub 2020 Oct 27.

Authors

Zaki Hassan-Smith¹, Wasim Hanif², Kamlesh Khunti³

Affiliations

¹ University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK. Electronic address: z.hassansmith@bham.ac.uk.
² University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK.
³ Diabetes Research Centre, College of Medicine, Biological Sciences and Psychology, University of Leicester, Leicester, UK.

PMID: 33125934
PMCID: PMC7832613
DOI: 10.1016/S0140-6736(20)32224-8

No abstract available

PubMed Disclaimer

Cited by

Analysis of efficacy of intervention strategies for COVID-19 transmission: A case study of Hong Kong.
Zhang N, Jack Chan PT, Jia W, Dung CH, Zhao P, Lei H, Su B, Xue P, Zhang W, Xie J, Li Y. Zhang N, et al. Environ Int. 2021 Nov;156:106723. doi: 10.1016/j.envint.2021.106723. Epub 2021 Jun 18. Environ Int. 2021. PMID: 34161908 Free PMC article.
A conceptual approach to the rationale for SARS-CoV-2 vaccine allocation prioritisation.
Kohns Vasconcelos M, Marazia C, Koniordou M, Fangerau H, Drexler I, Afum-Adjei Awuah A. Kohns Vasconcelos M, et al. Pathog Glob Health. 2021 Jul;115(5):273-276. doi: 10.1080/20477724.2021.1932136. Epub 2021 Jun 9. Pathog Glob Health. 2021. PMID: 34107233 Free PMC article.
Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.
Liu F, Zhao Z, Ma C, Nie X, Wu A, Li X. Liu F, et al. Epidemiol Infect. 2022 Jan 24;150:e46. doi: 10.1017/S0950268822000139. Epidemiol Infect. 2022. PMID: 35067231 Free PMC article.
Vaccination for Coronavirus Disease 2019 (COVID-19) and Relationship to Osteoporosis Care: Current Evidence and Suggested Approaches.
Tsourdi E, Yu EW, Jan de Beur SM, Drake MT. Tsourdi E, et al. J Bone Miner Res. 2021 Jun;36(6):1042-1047. doi: 10.1002/jbmr.4304. Epub 2021 Apr 14. J Bone Miner Res. 2021. PMID: 33831269 Free PMC article.
Maximising benefit, reducing inequalities and ensuring deliverability: Prioritisation of COVID-19 vaccination in the UK.
Campos-Matos I, Mandal S, Yates J, Ramsay M, Wilson J, Lim WS. Campos-Matos I, et al. Lancet Reg Health Eur. 2021 Mar;2:100021. doi: 10.1016/j.lanepe.2020.100021. Epub 2020 Dec 23. Lancet Reg Health Eur. 2021. PMID: 34173624 Free PMC article. Review. No abstract available.

See all "Cited by" articles

References

1. Department of Health and Social Care Joint Committee on Vaccination and Immunisation: interim advice on priority groups for COVID-19 vaccination. Sept 25, 2020. https://www.gov.uk/government/publications/priority-groups-for-coronavir...
1. Barron E, Bakhai C, Kar P. Type 1 and type 2 diabetes and COVID-19 related mortality in England: a whole population study. Lancet Diabetes Endocrinol. 2020;8:813–822. - PMC - PubMed
1. Khunti K, Routen A, Patel K. COVID-19 in Black, Asian and Minority Ethnic populations: an evidence review and recommendations from the South Asian Health Foundation. June 16, 2020. https://www.sahf.org.uk/covid19
1. Schaffer DeRoo S, Pudalov NJ, Fu LY. Planning for a COVID-19 vaccination program. JAMA. 2020;323:2458–2459. - PubMed
1. Hippisley-Cox J, Clift AK, Coupland CAC. Protocol for the development and evaluation of a tool for predicting risk of short-term adverse outcomes due to COVID-19 in the general UK population. medRxiv. 2020 doi: 10.1101/2020.06.28.20141986. published online June 29. (preprint) - DOI

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Department of Health and Social Care Joint Committee on Vaccination and Immunisation: interim advice on priority groups for COVID-19 vaccination. Sept 25, 2020. https://www.gov.uk/government/publications/priority-groups-for-coronavir...

[2] Department of Health and Social Care Joint Committee on Vaccination and Immunisation: interim advice on priority groups for COVID-19 vaccination. Sept 25, 2020. https://www.gov.uk/government/publications/priority-groups-for-coronavir...

[3] Barron E, Bakhai C, Kar P. Type 1 and type 2 diabetes and COVID-19 related mortality in England: a whole population study. Lancet Diabetes Endocrinol. 2020;8:813–822. - PMC - PubMed

[4] Barron E, Bakhai C, Kar P. Type 1 and type 2 diabetes and COVID-19 related mortality in England: a whole population study. Lancet Diabetes Endocrinol. 2020;8:813–822. - PMC - PubMed

[5] Khunti K, Routen A, Patel K. COVID-19 in Black, Asian and Minority Ethnic populations: an evidence review and recommendations from the South Asian Health Foundation. June 16, 2020. https://www.sahf.org.uk/covid19

[6] Khunti K, Routen A, Patel K. COVID-19 in Black, Asian and Minority Ethnic populations: an evidence review and recommendations from the South Asian Health Foundation. June 16, 2020. https://www.sahf.org.uk/covid19

[7] Schaffer DeRoo S, Pudalov NJ, Fu LY. Planning for a COVID-19 vaccination program. JAMA. 2020;323:2458–2459. - PubMed

[8] Schaffer DeRoo S, Pudalov NJ, Fu LY. Planning for a COVID-19 vaccination program. JAMA. 2020;323:2458–2459. - PubMed

[9] Hippisley-Cox J, Clift AK, Coupland CAC. Protocol for the development and evaluation of a tool for predicting risk of short-term adverse outcomes due to COVID-19 in the general UK population. medRxiv. 2020 doi: 10.1101/2020.06.28.20141986. published online June 29. (preprint) - DOI

[10] Hippisley-Cox J, Clift AK, Coupland CAC. Protocol for the development and evaluation of a tool for predicting risk of short-term adverse outcomes due to COVID-19 in the general UK population. medRxiv. 2020 doi: 10.1101/2020.06.28.20141986. published online June 29. (preprint) - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Who should be prioritised for COVID-19 vaccines?

Affiliations

Who should be prioritised for COVID-19 vaccines?

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical